Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 20/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2030110 | 0.94 | FDPS (0.40) | FDPS | |
| Methyl Phosphonate SCHEMBL14738769 | 0.93 | FDPS (0.42) | FDPS | |
| Phosphoric Acid SCHEMBL8002602 | 0.92 | FDPS (0.39) | FDPS | |
| Phosphoric Acid SCHEMBL3953980 | 0.91 | FDPS (0.43) | FDPS | |
| SCHEMBL1289988 | 0.91 | FDPS (0.37) | FDPS | |
| SCHEMBL669676 | 0.91 | FDPS (0.37) | FDPS | |
| SCHEMBL16389745 | 0.91 | FDPS (0.37) | FDPS | |
| SCHEMBL15348148 | 0.91 | FDPS (0.37) | FDPS | |
| SCHEMBL20543481 | 0.91 | FDPS (0.37) | FDPS | |
| Methyl Phosphonate SCHEMBL23113105 | 0.89 | FDPS (0.38) | FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250364645-A1 | ELECTROCHEMICAL CELLS WITH FLAME RETARDANT MECHANISM AND METHODS OF PRODUCING THE SAME | 24M TECHNOLOGIES, INC. (US) | 2025-11-27 | — | — | US | claimed |
| US-20250260054-A1 | ELECTRIC STORAGE DEVICE | Prime Planet Energy & Solutions, Inc. (JP) | 2025-08-14 | — | — | US | claimed |
| US-12381277-B2 | Electrochemical cells with flame retardant mechanism and methods of producing the same | 24M TECHNOLOGIES, INC. (US) | 2025-08-05 | — | — | US | claimed |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | Sud Chemie, Inc. (US) | 2024-12-24 | — | — | US | claimed |
| US-11634370-B2 | Selective hydrogenation methods | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-25 | — | — | US | claimed |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | CLARIANT INTERNATIONAL LTD (CH) | 2023-04-11 | — | — | US | claimed |
| CN-115768737-A | Selective hydrogenation process | 科莱恩国际有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115715280-A | Selective hydrogenation process and catalyst | 科莱恩国际有限公司 | 2023-02-24 | — | — | CN | claimed |
| US-20220052403-A1 | ELECTROCHEMICAL CELLS WITH FLAME RETARDANT MECHANISM AND METHODS OF PRODUCING THE SAME | 24M TECHNOLOGIES, INC. | 2022-02-17 | — | — | US | claimed |
| CN-113242847-A | Selective hydrogenation process | 科莱恩国际有限公司 | 2021-08-10 | — | — | CN | claimed |
| US-11059762-B2 | Selective hydrogenation methods | CLARIANT INTERNATIONAL LTD (CH) | 2021-07-13 | — | — | US | claimed |
| US-20200123082-A1 | SELECTIVE HYDROGENATION METHODS | CLARIANT INTERNATIONAL LTD (CH) | 2020-04-23 | — | — | US | claimed |
| US-20200123081-A1 | SELECTIVE HYDROGENATION METHODS | CLARIANT INTERNATIONAL LTD (CH) | 2020-04-23 | — | — | US | claimed |
| US-20200123083-A1 | SELECTIVE HYDROGENATION METHODS AND CATALYSTS | CLARIANT INTERNATIONAL LTD (CH) | 2020-04-23 | — | — | US | claimed |
| US-20200101446-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT INTERNATIONAL LTD. (CH) | 2020-04-02 | — | — | US | claimed |
| EP-2583751-B1 | Catalyst composition for selective hydrogenation with improved characteristics | CLARIANT PRODUKTE DEUTSCHLAND (DE) | 2014-12-03 | — | — | EP | claimed |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT CORPORATION | 2013-04-25 | — | — | US | claimed |
| WO-2013057244-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2013-04-25 | — | — | WO | claimed |
| EP-2583751-A1 | Catalyst composition for selective hydrogenation with improved characteristics | Clariant Produkte (Deutschland) GmbH (DE) | 2013-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12172147-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | FDPS 4438/4885 |
| US-20200101446-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | FDPS 4438/4885 |
| US-12172148-B2 | Catalyst composition for selective hydrogenation with improved characteristics | BET1, EP300, H1-2 | FDPS 4438/4885 |
| US-20200123083-A1 | SELECTIVE HYDROGENATION METHODS AND CATALYSTS | KAT8, ITGAV, ASNS | FDPS 2358/4885 |
| US-20200123082-A1 | SELECTIVE HYDROGENATION METHODS | KAT8, KAT7, TDO2 | FDPS 4019/4885 |
| US-11634370-B2 | Selective hydrogenation methods | KAT8, KAT7, TDO2 | FDPS 4019/4885 |
| US-11623902-B2 | Selective hydrogenation methods and catalysts | KAT8, ITGAV, ASNS | FDPS 2358/4885 |
| US-20130102819-A1 | CATALYST COMPOSITION FOR SELECTIVE HYDROGENATION WITH IMPROVED CHARACTERISTICS | BET1, EP300, H1-2 | FDPS 4466/4885 |
| US-20200123081-A1 | SELECTIVE HYDROGENATION METHODS | IDH2, CAT, ACAT1 | FDPS 2205/4885 |
| US-11059762-B2 | Selective hydrogenation methods | IDH2, CAT, ACAT1 | FDPS 2205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.